Tobacco Harm Reduction Education

Tobacco Harm Reduction Education

Throughout history, governments have often pursued idealistic solutions for complex issues like addiction to drugs, alcohol or junk food. Millions of people live lives that are detrimental to their health and need help from healthcare professionals. The two major strategies employed worldwide are discouraging people from engaging in behaviour harmful to their lives, which is called prevalence reduction and encouraging people to reduce the frequency or extent of the behaviour, which is called quantity reduction. However, these strategies have rarely been successful in sustainably changing outcomes. Given this knowledge, perhaps it’s time to focus on practical strategies that are in line with human behaviour to mitigate as much harm as possible. Harm reduction is a strategy used in medicine and social policy to minimise harm to individuals and/or wider society from hazardous behaviours or practices that cannot be completely avoided or prevented. Leading experts in their respective fields are producing accredited CME courses for healthcare professionals.

Overview of the Fratrem Group ‘Tabacco harm reduction’ division. The THR division operates in MENA, the UK, the USA, Europe and South Africa.

  • Three years of working within the highly regulated tobacco sector.
  • Three years of deep experience in the THR / RRP market sector.
  • Experienced in delivering online meetings, round tables, articles, white papers, courses, and in-person meetings.
  • Experience working at the government, policy and regulatory level.
  • Experience in developing key opinion leaders.
  • Deep knowledge of cigarettes, THP, Vapes, MOPs, and Standard Orals.
  • Deep understanding of the evidence of RRP and harm reduction.
  • Vast network of doctors and academics that are interested in THR.
  • Deep network of medical and scientific Key Opinion Leaders.

Below are examples of the courses that the Fratrem Group can deliver.

Harm reduction in healthcare and the impact on public health.

  • What is harm reduction in healthcare?
  • What is the impact on public health?
  • Overview of smoking statistics in the middle east.
  • Smoking cessation practices and challenges.
  • Review of harm reduction in smoking.
  • Obstacles to implementing harm reduction.
  • What is the evidence base for harm reduction in smoking.

Evidence review of Nicotine. Information for use in clinical practice.

  • What is the current perception of nicotine & common questions asked in clinic?
  • What does the evidence say about nicotine and Cancer?
  • What does the evidence say about nicotine and Heart disease?
  • What does the evidence say about nicotine and COPD?
  • What does the evidence say about how best to quit nicotine addiction?
  • What does the evidence say about using nicotine for harm reduction from smoking?

The science & review of the evidence of smoke-free alternatives.

  • Disc/Gum
  • Snus
  • Nicotine Pouch
  • E-cigarettes
  • Heated tobacco product
  • Aerosol heated tobacco product
  • Global and regional regulatory outlook on smoke-free alternatives

Alternatives to cigarettes: What are other countries doing?

  • Examples of poisons in a cigarette ?
  • What is nicotine?
  • What are the alternatives to cigarettes for people who will continue to smoke or people who will otherwise continue to smoke?
  • What is UK doing for people who will continue to smoke or people who will otherwise continue to smoke?
  • What is Sweden doing for people who will continue to smoke or people who will otherwise continue to smoke?
  • What is Japan doing for people who people who will continue to smoke or people who will otherwise continue to smoke?